Table 1.
Time spans (median and interquartile range)
| ACT | IQR | Placebo | IQR | All | IQR | |
|---|---|---|---|---|---|---|
| Duration of last forest stay before enrolment (days) | 8 | 4–13 | 8 | 5–14 | 8 | 5–12 |
| Days since last forest stay | 7 | 7–28 | 7 | 7–28 | 7 | 7–14 |
| Days between start drug administration* and return to forest | 19 | 19–28 | 19 | 18–20 | 19 | 18–19 |
| Days in forest | 8 | 5–12 | 10 | 3–10 | 9.5 | 5–10 |
| Days between return to forest and last screening | 28 | 23–34 | 28 | 23–34 | 28 | 23–34 |
| Duration of study participation (days) | 47 | 42–54 | 47 | 42–54 | 47 | 42–54 |
* 3 days DHA/piperaquine and 14 days PQ